Two doses of a simple tuberculosis vaccine after surgery support the immune system in fighting cancer cells and could significantly improve treatment outcomes for the most common form of bladder cancer, according to a pilot study involving 40 patients. Initial results of the RUTIVAC-1 study were presented at EAU25.
Autoren
- Birke Dikken
Publikation
- InFo ONKOLOGIE & HÄMATOLOGIE
Related Topics
You May Also Like
- Gastrointestinal complaints
PPI regulation under the microscope
- Study report
Digital patient education for atrial fibrillation shows measurable effects
- Important basics and studies on cancer and the psyche
Interplay between cancer and mental illness
- IBDmatters - Synergy effects for IBD pathways
How combination therapies lead to better treatment results
- "Patients W.A.I.T. Indicator"
Access to new drugs is becoming increasingly difficult
- Cardiometabolic research
The liver-heart axis in the pathogenesis of cardiometabolic diseases
- ASCO 2025
Supportive therapies for greater adherence and compliance
- Heart rhythm